Geode Capital Management’s Axcella Health Inc. Common Stock AXLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-11,022
| Closed | -$115K | – | 4804 |
|
|
2023
Q3 | $115K | Sell |
11,022
-2,511
| -19% | -$19.8K | ﹤0.01% | 4197 |
|
|
2023
Q2 | $73.9K | Hold |
13,533
| – | – | ﹤0.01% | 4423 |
|
|
2023
Q1 | $162K | Buy |
13,533
+3,959
| +41% | +$52.8K | ﹤0.01% | 4144 |
|
|
2022
Q4 | $78K | Buy |
9,574
+1,134
| +13% | +$29.4K | ﹤0.01% | 4482 |
|
|
2022
Q3 | $360K | Buy |
8,440
+23
| +0.3% | +$1.22K | ﹤0.01% | 3904 |
|
|
2022
Q2 | $427K | Buy |
8,417
+2,588
| +44% | +$127K | ﹤0.01% | 3848 |
|
|
2022
Q1 | $374K | Buy |
5,829
+209
| +4% | +$10.4K | ﹤0.01% | 4088 |
|
|
2021
Q4 | $293K | Hold |
5,620
| – | – | ﹤0.01% | 4302 |
|
|
2021
Q3 | $418K | Buy |
5,620
+145
| +3% | +$12.4K | ﹤0.01% | 4113 |
|
|
2021
Q2 | $548K | Sell |
5,475
-3,752
| -41% | -$372K | ﹤0.01% | 3901 |
|
|
2021
Q1 | $1.1M | Buy |
9,227
+386
| +4% | +$54.5K | ﹤0.01% | 3513 |
|
|
2020
Q4 | $1.15M | Buy |
8,841
+1,477
| +20% | +$190K | ﹤0.01% | 3327 |
|
|
2020
Q3 | $850K | Buy |
7,364
+1,060
| +17% | +$131K | ﹤0.01% | 3266 |
|
|
2020
Q2 | $871K | Buy |
6,304
+4,636
| +278% | +$567K | ﹤0.01% | 3187 |
|
|
2020
Q1 | $142K | Buy |
1,668
+112
| +7% | +$11.5K | ﹤0.01% | 3651 |
|
|
2019
Q4 | $155K | Buy |
+1,556
| New | +$171K | ﹤0.01% | 3883 |
|
Other funds holding AXLA
Geode Capital Management's AXLA Position: Q4 2023 in Review
Geode Capital Management sold out of Axcella Health Inc. Common Stock (AXLA) in Q4 2023, closing a stake of 11,022 shares — an estimated $115K sold.
Geode Capital Management first reported a position in AXLA in Q4 2019 and held it in 16 quarters. The position peaked at $1.15M in Q4 2020. 1 fund tracked by Wall St. Rank holds AXLA as of Q4 2023.
- Geode Capital Management reported no remaining Axcella Health Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Geode Capital Management sold 11,022 Axcella Health Inc. Common Stock shares in Q4 2023, an estimated $115K.
- Geode Capital Management first reported a position in Axcella Health Inc. Common Stock in Q4 2019 and held it in 16 quarters.
- Geode Capital Management's Axcella Health Inc. Common Stock position peaked at $1.15M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q4 2023.
Based on Geode Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.